Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Energy spending in the may protect the heart during

In , a may spend to sustain and limit damage during repeated signals that mimic early fasting. Testing must first establish sufficient joint activity of and ; its absence rejects this implementation.

Stage of verification

  1. Hypothesis published2026-10-06
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionHeart and blood vessels

Biological function

The proposed local glutamine–glutamate cycle in cardiomyocytes couples opposing glutamine synthesis and hydrolysis reactions to limited adenosine triphosphate consumption, creating demand for adenosine diphosphate phosphorylation. Muscle-derived glutamine replenishes the cycling pool, while its net oxidation supplies only a small fraction of the energy.Energy-consuming glutamine cycling

Direction

A double ring marks the main placement where a group contains several values.

Lens
Thermodynamic substrate cycling
Goal
Согласованность миметического сигнала с ресурсной обеспеченностью и естественной потребностью
Competing hypotheses
4
Published
2026-10-06
As a hypothesis
8 / 10Clarity of mechanism
5 / 10Few extra conditions
9 / 10Completeness of the answer
6 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
3 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolism and energy

    The cycle of breakdown to and resynthesis that consumes ATP

    Where this hypothesis actsIn the target tissue during repeated pulses and delayed feeding, tested in cardiomyocytes

    Hypotheses on this target 1
    Glutamine–glutamate cycleInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 11Function preservation. Hypotheses on this target 0Supplementation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition
    • Activation1
    • Function preservation
    • Supplementation
    • Feedback restoration
    • Direct measurement

    What is proposed

    Activation

    Reproduce a brief local ATP-consuming cycle supported mainly by other fuels

    With whatNot stated in the record

    HowA proposed mimetic would sustain simultaneous and activity, with other fuels providing most of the energy

    Possible result

    Possible reduction in respiratory-chain over-reduction, damaging and residual heart damage

    From the recordновый миметик должен воспроизводить короткий локальный цикл расходования энергии, поддерживая его преимущественно другими видами топлива.

  2. Enzyme

    An enzyme involved in binding through formation

    Where this hypothesis actsIn cardiomyocytes exposed to the , with supply and preserved

    Hypotheses on this target 2
    Glutamine synthetaseInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 0Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Replacement. Hypotheses on this target 0Protection from degradation. Hypotheses on this target 0Cofactor removal. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Inhibition
    • Activation
    • Lower level
    • Higher level
    • Replacement
    • Protection from degradation
    • Cofactor removal
    • Synthesis suppression
    • Function preservation

    What is proposed

    Partially suppress to test whether cycling is required for protection

    HowPartial suppression in cardiomyocytes while maintaining supply and ; the suppression technique is not stated

    Possible result

    Expected higher ATP-to-ADP ratio, greater and loss of mimetic protection

    From the recordПри неизменном поступлении глутамина и сохранённой GLS1 частичное подавление GLUL в кардиомиоцитах уменьшает встречные потоки синтеза и гидролиза глутамина

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKmTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαGlutamine synthetase. Hypotheses on this target 2Glutamine synthetase
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycle
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Protecting the heart when food is delayed might depend on how it spends energy, as well as how much energy it has. The unexpected move is a proposal that repeatedly converting , a molecule that carries carbon and nitrogen, into , a related molecule, and back could protect the heart by consuming energy. This is a hypothesis generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. Repeated signals that imitate early fasting are proposed to engage simultaneous and activity in heart cells.
  2. converts to , while converts back to and consumes ATP.
  3. ATP consumption increases the demand to convert , or ADP, the lower-energy partner of ATP, back into ATP.
  4. That demand is proposed to accelerate and shift the , the series of electron-transfer reactions supporting ATP production, from excessive electron accumulation toward more active electron transfer.
  5. The shift is proposed to reduce production of damaging and preserve heart-cell function.
  6. Muscle-derived replenishes the local cycling supply, while other fuels provide most of the energy.
  7. Repeated reductions in lasting heart damage are proposed to contribute to longer life.
A picture for it

A small outlet can keep water moving through a pipe that would otherwise remain backed up. Closing the outlet saves water but also removes the flow it maintained.

Where the picture breaks: Cells do not protect themselves by relieving literal water pressure. The proposal concerns energy demand and electron transfer, and the picture does not establish that this particular cycle is large enough to change either.

  1. Master questionstep 01 of 04

    Imitating selected natural body processes could offer new ways to extend life through substances, combinations of substances, or other interventions.

    Rests on: The goal explicitly calls for new hypotheses connecting imitation of a natural process to a possible benefit for lifespan.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    A signal that imitates a natural process should match the resources available to the body and its actual need for that process.

    Rests on: The master question seeks useful imitation of natural processes; this stage adds resource availability and need as conditions for usefulness.

    Assumption

    The chain takes alignment between the signal, available resources, and actual need as a governing requirement; the master question does not establish that requirement.

  3. Gap questionstep 03 of 04

    An intervention that imitates early fasting might preserve energy in one tissue by drawing from muscle, with protection lost when that supply is interrupted during delayed feeding.

    Rests on: The resource requirement motivates examining whether protection in one tissue consumes resources from another.

    Leap

    The preceding stage supplies the general resource question but no basis for selecting muscle-derived as the transfer that sustains protection. The supplied sources do not establish that transfer during simulated fasting.

  4. Hypothesisstep 04 of 04

    Heart protection is proposed to depend on spending a limited amount of , or ATP, the molecule cells use to power work. 1, or , converts into , while , or , makes again using ATP. Their simultaneous activity is proposed to stimulate , the process that helps replenish ATP, and reduce damaging , chemically reactive molecules that can injure cells. Muscle would replenish the cycling material while other fuels supply most of the energy.

    Rests on: The preceding question supplies the proposed dependence on muscle and the loss of protection when exchange is interrupted. The endpoint offers an energy-spending cycle as the explanation, replacing the expectation that mainly preserves energy by serving as fuel.

    Stated in the chain

What is carried, and what is not. None of the supplied screened sources establishes the proposed energy-spending cycle or its specific causal links to heart protection; source S4, a 2021 study in Biochemical and Biophysical Research Communications, instead reports that breakdown helped maintain ATP and , a molecule used in cellular antioxidant defenses, in newborn rat heart cells exposed to damaging , which supports a competing explanation but does not establish what happens during simulated fasting in an intact organism. No supplied source establishes the proposed sequence through reduced lasting heart damage to longer life.S4

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The chain takes alignment between the signal, available resources, and actual need as a governing requirement; the master question does not establish that requirement.
  • Gap question. The preceding stage supplies the general resource question but no basis for selecting muscle-derived as the transfer that sustains protection. The supplied sources do not establish that transfer during simulated fasting. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A loss of protection after reducing could be credited to stopping energy expenditure even if the intended cycle was never sufficiently active or its opposing reactions were not actually reduced. What closes it: The specification requires confirming sufficient simultaneous and activity first. Tracing carbon and , the nitrogen in 's amide chemical group, must then establish the opposing conversion rates, with supply and activity maintained as specified.
  • A higher ATP-to-ADP ratio could be read as proof that stopping the cycle improved energy production, although the proposal predicts that the ratio could rise because energy consumption fell. What closes it: The ratio must be measured alongside and the opposing conversion rates. Electron accumulation in the , oxidant production, and heart-cell protection must also be assessed rather than inferred from the ratio alone.
  • Restoring protection with an , an added activity that consumes ATP, could be attributed to energy spending even if the intervention also restores a rival protective route. What closes it: The proposed rescue requires comparable , a nitrogen-containing product associated with these reactions, , and , the attachment of sugars to molecules such as proteins. Separating the rival explanation based on connected , the cell structures that support , also requires measuring or controlling that connectivity; this is not specified in the supplied test.

What would make this wrong. The specified implementation is rejected if the chosen heart cells lack sufficient simultaneous and activity. If both are active, verified suppression of the opposing conversions that leaves protection intact under the specified conditions would contradict the cycle's claimed necessity. Failure of a verified additional ATP-consuming load to restore protection under the specified matched conditions would contradict the distinctive rescue prediction.

What it would change. If the mechanism held, an intervention intended to imitate a useful natural process might need to reproduce a brief local demand for energy, supported mainly by other fuels. Preserving ATP alone would then be an inadequate measure of whether the intended heart protection had been reproduced. Even a successful cell experiment would leave muscle costs, protection during repeated treatment in an intact organism, lasting heart damage, and lifespan benefits unestablished; the supplied specification does not identify a species for the proposed test.

Sources read · 6

6 literature searches, 3 full texts, 5 abstract-only; 8 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S2Partly answers it

USP16 S-nitrosylation aggravates coronary microembolization-induced myocardial injury via repressing KDM1A-mediated glutathione homeostasis. · Nature communications · 2025

“This study found that GCLM and GLS protein levels were strikingly reduced by CME and that the overexpression of GCLM or GLS protected against CME-induced myocardial injury.”

Does not settle: The source does not test fasting mimicry, simultaneous GLS1 and GLUL activity, ATP consumption, respiratory-chain reduction, muscle-derived glutamine, fuel contributions, cycle disruption, repeated treatment pulses, residual heart damage, or lifespan.

S3Background

Glutamine uptake and catabolism is required for myofibroblast formation and persistence. · Journal of molecular and cellular cardiology · 2022

“Pharmacological and genetic inhibition of glutaminolysis prevented myofibroblast formation indicated by a reduction in αSMA+ cells, collagen gel contraction, collagen abundance, and the bioenergetic response.”

Does not settle: Источник изучает глутаминолиз в сердечных фибробластах. Он не устанавливает наличие цикла GLS1-GLUL, расход АТФ этим циклом, влияние на дыхательную цепь и образование окислителей, защиту сердца при имитации голодания, вклад мышечного глутамина или связь механизма с продлением жизни.

S4Contradicts it

Critical role of glutamine metabolism in cardiomyocytes under oxidative stress. · Biochemical and biophysical research communications · 2021

“Our study demonstrates that under oxidative stress, glutaminolysis is upregulated to compensate for the loss of αKG and its replenishment into the TCA cycle, thereby exerting cardioprotective effects by maintaining ATP and GSH levels.”

Does not settle: Источник не исследует GLUL, одновременную работу GLS1 и GLUL, расходование АТФ в цикле глутамин-глутамат, миметик голодания, задержку питания, восстановленность дыхательной цепи, образование окислителей, остаточное повреждение сердца или продолжительность жизни. Опыты проведены на неонатальных кардиомиоцитах крысы при окислительном стрессе, поэтому источник не устанавливает этот механизм в ткани сердца целого организма.

S6BackgroundAbstract only

Metabolic adjustments during semi-aestivation of the marble swamp eel (Synbranchus marmoratus, Bloch 1795)--a facultative air breathing fish. · Brazilian journal of biology = Revista brasleira de biologia · 2005

“Lactate dehydrogenase, glutamate dehydrogenase, malate dehydrogenase, aspartate amino transferase, alanine amino transferase, glutamine synthase, ornithine carbamoyl transferase, and arginase enzymes were assayed.”

Does not settle: Источник не устанавливает наличие цикла GLS1-GLUL в сердце, расход АТФ этим циклом, его влияние на дыхание и образование окислителей, вклад мышечного глутамина, защиту сердца при повторных импульсах миметика голодания или связь с продолжительностью жизни. Исследование ограничено полуспячкой мраморного болотного угря длительностью 15 и 45 дней.

S7BackgroundAbstract only

A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. · Physiological genomics · 2006

“Across all tissues, there was a profound decrease in glucose and a number of amino acids, including glutamine and alanine, and an increase in lactate, demonstrating that a failure to express PPAR-alpha results in perturbations in glycolysis, the citric acid cycle, and gluconeogenesis.”

Does not settle: The source does not establish a glutamine–glutamate cycle involving GLS1 and GLUL, ATP expenditure, respiratory-chain redox state, oxidant production, cardiac protection during fasting mimicry, muscle-to-heart glutamine transfer, residual heart damage, or lifespan effects.

S8BackgroundAbstract only

Plasma concentrations and tissue uptake of free amino acids in dogs in sepsis and starvation: effects of glucose infusion--some effects of low alimentation. · Metabolism: clinical and experimental · 1978

“The free concentrations of amino acids in the liver, heart, and muscle tissues were grossly elevated in the low intravenous alimented septic state relative to the fasted normal state”

Does not settle: Источник не устанавливает наличие цикла глутамин-глутамат в сердце, активность GLS1 или GLUL, расход АТФ, скорость дыхания, образование окислителей, защиту сердца при имитации голодания или влияние этого механизма на продолжительность жизни.

The gap this hypothesis explains

Does copying early fasting preserve tissue energy using muscle fuel, with protection during delayed feeding requiring this transfer?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Может ли сохранять энергию ценой расходования мышечного , и устраняет ли разрыв этого обмена защитный эффект при задержке питания?

What this question is asking

The question concerns whether a treatment that imitates the body's early response to going without food protects one tissue by drawing on fuel supplied by muscle. That fuel is , an amino acid that muscles produce and release and that other tissues can use. It asks whether the treatment preserves energy in the receiving tissue while feeding is delayed, compared with the same conditions without treatment. It then asks whether blocking the proposed transfer removes that protection compared with leaving the transfer intact. The treatment, receiving tissue, duration of the feeding delay and measures of energy and protection are unspecified; the proposed exchange is a possibility being questioned, rather than an established fact.

What the terms mean
Early fasting
The initial period of going without food. The question gives no duration or specific bodily response that defines this period.
Fasting mimetic
A treatment intended to imitate some response to going without food. This names a proposed kind of intervention, not a specified substance or a demonstrated reproduction of every effect of fasting.
Glutamine
An amino acid, one of the substances used to make proteins, that also has other roles in the body. Here it is the proposed muscle-supplied fuel; S1 describes both its fuel role and its role in supporting production of genetic-information molecules.
Skeletal muscle
Muscle used to move and support the body. In this question it is the proposed source of supplied to another tissue.
Receiving tissue
The part of the body proposed to benefit from muscle-supplied . The question does not identify it, so the gut and kidney findings cannot automatically stand for the intended tissue.
Tissue energy preservation
Maintaining a tissue's available energy or ability to meet its energy needs. The question does not specify how this would be measured, and repair alone is not a stated measurement of it.
Glutamine transfer
The proposed passage of from muscle to a receiving tissue for use there. Increased release from muscle establishes only part of that proposed connection.
Delayed feeding
Food or nutritional supply arriving later than it otherwise would. Neither the length of the delay nor the feeding conditions are supplied.
Protection
A reduction in tissue harm or preservation of tissue function. The question does not define the outcome that would count as protection or establish that it is identical to maintaining energy.
Ketone bodies
A class of molecules the body can use as fuel during fasting. S2 examines elevated concentrations in relation to amino acid release from muscles of fasted birds.
Alanine and glutamate
Two amino acids involved in the muscle response described by S2. That source reports a shift away from alanine release and attributes increased production to greater availability.
Glucocorticoids
A class of hormones involved in responses to stress and regulation of how the body uses its resources. S3 describes them promoting protein breakdown, which increases muscle release.
Protein breakdown
The dismantling of proteins into smaller components, including amino acids. S3 places this process between the hormone response and increased supply for gut repair.
Gut lining and immune cells
The gut lining is the layer of cells facing the inside of the digestive tract; immune cells participate in the body's defenses. These are reported recipients or users of in S1 and S3.
Dexamethasone
A drug in the glucocorticoid class. S4 includes treatment with it among the settings associated with increased muscle release in sheep; the supplied material does not establish it as the fasting mimetic asked about.
What turns on the answer
  • Energy is preserved, and blocking transfer removes protection Under this outcome, the treatment's benefit would depend on the muscle-to-tissue transfer under the conditions examined. Protection during delayed feeding would therefore require continued access to that supply, although a harmful cost to muscle would remain a separate question.
  • Energy is preserved, but protection survives blocked transfer If the transfer were successfully blocked and protection remained, that transfer would not be necessary for the observed protection. Muscle release could accompany the treatment without explaining why the receiving tissue remains protected.
  • The treatment does not preserve tissue energy The proposed energy benefit would not occur under the conditions examined. Even if muscle released more , that release would not establish the protective exchange described in the question.
Why it matters

Muscle-produced can supply fuel to cells lining internal surfaces and to immune cells, providing a reported starting point for the proposed connection between tissues [S1]. If a treatment preserves another tissue's energy by increasing its use of this supply, that benefit could depend on a continuing contribution from muscle. Increased release alone, however, would not establish either a damaging cost to muscle or protection of the receiving tissue. Mistaking release for demonstrated protection would overstate the evidence, while assuming protection is independent of muscle supply could conceal the dependency the question asks about.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Радикальная гипотеза: защиту от повторных обеспечивает ограниченное расходование в внутри . Одновременная работа и создаёт дополнительную потребность в . Это ускоряет , уменьшает чрезмерную и образование повреждающих . Мышечный пополняет , но его чистое даёт лишь малую часть энергии. При задержке питания разрыв цикла способен повысить содержание и одновременно уничтожить защиту. Если механизм подтвердится, новый должен воспроизводить короткий локальный цикл расходования энергии, поддерживая его преимущественно другими видами топлива. Предполагаемая цепь к продлению жизни проходит через снижение остаточного повреждения сердца. Стабилизируемое свойство: SPV_3.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При неизменном поступлении и сохранённой частичное в уменьшает и , повышает , но увеличивает и устраняет защиту . В регулируемая дополнительная восстанавливает защиту при сопоставимых , и . Простое энергетическое восполнение при отсутствии такого оборота защиты не возвращает.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies directional biochemical changes, loss of protection, and contrasting conditions that restore or fail to restore protection. These outcomes are measurable without numerical thresholds. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

можно оценить совместным , и энергетическое состояние измерить независимо. Первый обязательный этап: подтвердить достаточную совместную активность и в выбранной клетке. Её отсутствие отвергает эту реализацию ещё до опытов на продолжительность жизни.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При неизменном поступлении и сохранённой частичное в уменьшает и , повышает , но увеличивает и устраняет защиту . В регулируемая дополнительная восстанавливает защиту при сопоставимых , и . Простое энергетическое восполнение при отсутствии такого оборота защиты не возвращает.

  • What would separate them

    Early-fasting mimetics may protect the heart by burning glutamine supplied by muscle predicts: У старых мышей при задержке питания увеличивает из задней конечности и его в сердца. Избирательное сердечной снижает образование раньше появления повреждений и устраняет защиту. В альтернативное окисляемое топливо восстанавливает защиту при сохранённой , если экспериментально подтверждено восстановление . При повторных циклах величина мышечной потери связана с и недостаточным .

  • What would separate them

    Connected mitochondria may protect ageing heart cells when muscle glutamine supply falls predicts: При сопоставимых массе , и доступности топлива зависимость функции сердца от имеет , положение которого меняется при изменении . Увеличение сохраняет защиту после при низком поступлении мышечного . отменяет этот эффект даже при восстановленных и . должен воспроизводиться при двух независимых способах изменения .

  • What would separate them

    Muscle glutamine may protect the heart by supporting glutathione-dependent lipid peroxide removal predicts: После сердечной растут раньше падения . В -1 либо подтверждённое восстановление внутриклеточного возвращает защиту при сохраняющемся снижении . Альтернативное топливо, восстановившее , сохраняет недостаточную защиту. После обхода частичное не должно воспроизводить обязательную потерю защиты, предсказанную another hypothesis of the same gap.

  • What would separate them

    Muscle glutamine may protect the heart by supplying nitrogen for protein glycosylation predicts: увеличивает включение амидного в . Частичное устраняет защиту при сохранённых и . восстанавливает защиту и уменьшает потребность в поступающем только при работоспособном . Частичное сохраняет или усиливает защиту при доступном альтернативном топливе. использования отменяет специфическое восстановление.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

в показывает физиологически полезное расходование энергии: [Kazak et al., Cell, 2015](https://pubmed.ncbi.nlm.nih.gov/26496606/). Отдельно показано раннее включение при недостатке : [Cell Research, 2024](https://www.nature.com/articles/s41422-024-00985-6). Эти наблюдения обосновывают возможность гипотезы, но непосредственно сердечный не подтверждают.

Subfield revised

голодания; пересмотра потребовал бы раздел учебника « и ». Конкретно пришлось бы отказаться от объяснения необходимого глутаминового потока преимущественно его чистым энергетическим выходом для этого .

Testable surprise

Прекращение расходования повышает и ухудшает выживание ; восстановление дозированной возвращает защиту при выключенном .

Why this is not the mainstream account

В проверенных публикациях не найдено утверждения, что необходимая защита от в старом сердце определяется с чистым расходованием . Ограниченный поиск не доказывает отсутствия такого утверждения во всей литературе; строгий критерий новизны остаётся неподтверждённым.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.